MSB 1.49% 99.5¢ mesoblast limited

"Meeting with FDA, expected within 30 days, to discuss a...

  1. 770 Posts.
    lightbulb Created with Sketch. 117
    "Meeting with FDA, expected within 30 days, to discuss a potential accelerated approval with a post-approval condition for an additional study."
    When you read it, the FDA could approve the treatment with the condition of an additional study. Not as bad as first presented!!!!! Could be approved soon with conditional study! that's my take on it. Buy in cheap!!!!!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.5¢
Change
-0.015(1.49%)
Mkt cap ! $1.136B
Open High Low Value Volume
$1.02 $1.02 99.5¢ $2.005M 1.991M

Buyers (Bids)

No. Vol. Price($)
3 14424 99.5¢
 

Sellers (Offers)

Price($) Vol. No.
$1.00 63643 1
View Market Depth
Last trade - 16.10pm 19/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.